Making the step from academia into industry can seem daunting and can appear to require a very different skill set.
In April, Synpromics attended the 6th annual Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day in New York, a full-day conference featuring discussi
Edinburgh, UK, 3rd May 2018 / Synpromics Ltd, the leader in gene control, today announced it has been awarded a £1.9m research and development grant from
Edinburgh, UK, 23rd April 2018 / Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducibl
As product developers move toward 2nd generation gene and cell medicine constructs, the importance of novel gene regulation and promoter elements has emerged.